At the beginning of the New Year, Exploration of Targeted Anti-tumor Therapy is pleased to announce the “Highly Cited Paper Award” to recognize the most highly cited papers in 2020-2021, and to show our appreciation to those authors.
Eligibility for the awards:
– Original research articles and reviews published in 2020 and 2021;
– Both regular and Special Issue submissions will be considered;
– Citations will be counted according to Web of Science in 2020 and 2021.
After careful evaluation, six articles have been selected, and the author teams will be awarded $1000, $600 and $300 respectively. The authors will also receive a “Highly Cited Paper Award” certificate issued by the journal. In addition, the corresponding Guest Editor will also be awarded $300, $200 and $100 respectively.
1st Prize:
★Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan*, Matthias G. J. Baud*
Special Issue: Proteolysis Targeting Chimera (PROTAC)
2nd Prize:
★The impact of tumour pH on cancer progression: strategies for clinical intervention
Carol Ward, James Meehan, Mark E Gray, Alan F Murray, David J Argyle, Ian H Kunkler, Simon P Langdon*
★Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients
Paola Castillo, Marta Marginet, Pedro Jares, Mireia García, Elena Gonzalvo, Ana Arance, Adriana García, Llucia Alos, Cristina Teixido*
3rd Prize:
★Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
Sosmitha Girisa, Dey Parama, Choudhary Harsha, Kishore Banik, Ajaikumar B. Kunnumakkara*
Special Issue: Targeting Transcription Factors for Cancer Therapy
★Role of liquid biopsy for thoracic cancers immunotherapy
Raimondo Di Liello*, Flora Cimmino, Soraya Simón, Emilio Francesco Giunta, Vincenzo De Falco, Paloma Martín-Martorell
Special Issue: Liquid Biopsy in Thoracic Cancer
★Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors
Rachael Arthur, Beatriz Valle-Argos, Andrew J. Steele, Graham Packham*
Special Issue: Proteolysis Targeting Chimera (PROTAC)
Congratulations to these authors! On behalf of the Editorial Board and Editorial Office, we sincerely appreciate the great supports they provided to this new journal at its early stage. In the following year, we will continue to set the Highly Cited Paper Award to recognize authors who contribute high-quality publications to the journal. Meanwhile, we warmly welcome more outstanding experts to join us and make this journal to be an influential one in the cancer research field.